New York legal firm Weisslaw said in a press release it is “investigating possible breaches of fiduciary duty and other violations of law” by the board of Alberton in connection with the SPAC’s proposed merger with SolarMax Technology. WeissLaw said it is looking into whether the Alberton board acted in the best interest of the company’s shareholders in agreeing to the proposed transaction, whether the board was fully informed on the valuation of SolarMax, whether the deal’s equity split is fair to ALAC shareholders, and whether all information regarding the valuation “will be fully and fairly disclosed.” Read more.
Related Posts
First Reserve Sustainable Growth Prices $200M IPO
First Reserve plans to target companies engaged in energy transition toward a low-carbon future.
CM Life Sciences Merging With Sema4 in $793M Deal
The combination is expected to provide up to $793 million in cash proceeds to shareholders and Sema4.
Lights Out at Intelligent Medicine
The SPAC raised $180 million in a November 2021 IPO to focus on life science companies that are using artificial intelligence, machine learning and big data to power drug discovery.
Social Leverage I Prices $300M IPO
The SPAC will target the fintech, enterprise software or consumer technology sectors.